Park Medi World Limited has submitted its Monitoring Agency Report for the quarter ended September 30, 2026. The report, issued by CRISIL Ratings Limited, details the utilization of funds raised through the company’s Initial Public Offering (IPO). A key finding indicates a deviation in fund utilization from the original prospectus objects, which was subsequently approved by shareholders for the reallocation towards capital expenditure for the acquisition of The Medicity Hospital, Rudrapur.
Park Medi World Limited Discloses IPO Fund Utilization for Q3 2026
Park Medi World Limited has officially released its Monitoring Agency Report for the quarter that concluded on September 30, 2026. This report, prepared by CRISIL Ratings Limited, provides a comprehensive overview of how the proceeds from the company’s Initial Public Offering (IPO) have been utilized during the specified period.
Key Findings from the Report
The report highlights a deviation in the utilization of funds compared to the initial objects stated in the Prospectus. Specifically, the utilization was found to be in line with a shareholder-approved change of objects. This approval, obtained on September 3, 2026, allowed for the reallocation of ₹648.32 million from earlier stated objects to a new objective: ‘Funding capital expenditure regarding acquisition of The Medicity Hospital, Rudrapur’.
This strategic reallocation was driven by the company’s objective to strengthen its regional presence, accelerate revenue and profit generation, and support its long-term growth strategy through the acquisition of an operational hospital. The reallocated amount is intended to fund the acquisition of ‘V3 Healthcare Private Limited’, the owner and operator of ‘The Medicity Hospital, Rudrapur’.
Utilization Details
As of September 30, 2026, the report indicates that the entire IPO proceeds have been fully utilized. The total issue proceeds amounted to ₹7,700.00 million, with issue expenses totaling ₹567.23 million, resulting in net proceeds of ₹7,132.77 million.
The report also details the progress against each specific object:
- Repayment/prepayment of outstanding borrowings: Fully utilized.
- Funding capital expenditure for development of new hospital by Subsidiary Park Medicity (NCR): Fully utilized.
- Funding capital expenditure for purchase of medical equipment: Fully utilized.
- Unidentified inorganic acquisitions and general corporate purposes: Fully utilized.
- Funding capital expenditure regarding acquisition of The Medicity Hospital, Rudrapur: Fully utilized, with ₹648.32 million allocated to this object.
The report clarifies that the entire issue proceeds have been fully utilized as at the quarter ended September 30, 2026, making this the final Monitoring Agency report for the IPO proceeds.
Source: BSE
